News center

Prensa/News center

The most outstanding

Grupo SURA has signed an agreement with Grupo Argos in order to move forward with a transaction that while simplifying its shareholding structure shall allow it to focus its portfolio more on the financial service sector

Publicado el 18 December 2024

SURA is celebrating 80 years of growth and progress in both Colombia and Latin America

Publicado el 12 December 2024

In terms of sustainability, Grupo SURA outperformed 98% of the organizations from its own sector, according to S&P Global

Publicado el 17 December 2024

Grupo SURA consolidated earnings totaling COP 5.7 trillion at the end of Q3 2024, thereby reflecting the strength of its investments and the progress made in terms of its profitability

Publicado el 14 November 2024

Construction begins on VaxThera plant to produce vaccines and biologicals for Colombia and the rest of the region

Publicado el 02 February 2022

Country Code Survey*

Publicado el 31 January 2022

Board Decisions*

Publicado el 27 January 2022

Changes of more than five percent (5%) to the shareholding structure corresponding to the Company´s outstanding shares*

Publicado el 20 January 2022

Measures taken by Grupo SURA in connection with the tender offer allocated on Friday, January 14, and the request for a new tender offer.*

Publicado el 16 January 2022

Grupo SURA advances with the payment of dividends 2022

Publicado el 03 January 2022

Clarification on the acceptance percentages corresponding to the tender offer for Grupo SURA shares*

Publicado el 30 December 2021

Clarification regarding some publications appearing in certain media outlets with respect to Grupo Sura and its related companies. *

Publicado el 24 December 2021

Colombia signs an agreement governing the co -development of vaccines using mRNA technology

Publicado el 16 December 2021

Contacts for exclusive attention of journalists

Grupo SURA

Juan Fernando Rojas

jfrojas@gruposura.com.co

Colombia

Suramericana

Diana Sánchez

dcsanchez@sura.com

Colombia

SURA Asset Management

Luis Felipe Posada

luis.posada@sura-am.com

Colombia

News center - Grupo Sura

Our strategy

Consult

Check

Access Recent Photos, Videos, and Infographics from the Company

The most outstanding

Grupo SURA has signed an agreement with Grupo Argos in order to move forward with a transaction that while simplifying its shareholding structure shall allow it to focus its portfolio more on the financial service sector

SURA is celebrating 80 years of growth and progress in both Colombia and Latin America

In terms of sustainability, Grupo SURA outperformed 98% of the organizations from its own sector, according to S&P Global

Grupo SURA consolidated earnings totaling COP 5.7 trillion at the end of Q3 2024, thereby reflecting the strength of its investments and the progress made in terms of its profitability

News Center

Construction begins on VaxThera plant to produce vaccines and biologicals for Colombia and the rest of the region

Country Code Survey*

Board Decisions*

Changes of more than five percent (5%) to the shareholding structure corresponding to the Company´s outstanding shares*

Measures taken by Grupo SURA in connection with the tender offer allocated on Friday, January 14, and the request for a new tender offer.*

Grupo SURA advances with the payment of dividends 2022

Clarification on the acceptance percentages corresponding to the tender offer for Grupo SURA shares*

Clarification regarding some publications appearing in certain media outlets with respect to Grupo Sura and its related companies. *

Colombia signs an agreement governing the co -development of vaccines using mRNA technology

Contacts for exclusive attention of journalists

Juan Fernando Rojas

Diana Sánchez

Luis Felipe Posada

Informational modal regarding the use of Cookies